Dr. Geoff Oxnard Discusses the Role of Precision Medicine in Lung Cancer Research

Patient from Hell Ep 62: Transforming Lung Cancer Treatment using Precision MedicineПодробнее

Lung Cancer Webchat: What You Need to Know About Treatment and ResearchПодробнее

2021 OneOncology | Advancing Precision Oncology in the Community | Liquid BiopsyПодробнее

Precision Medicine for Lung CancerПодробнее

Geoffrey Oxnard, MD, on the FLAURA study impacting treatment selection in EGFR mutant lung cancerПодробнее

Dr. Bunn on Current Role of Precision Medicine for Lung CancerПодробнее

Dr. Oxnard on the Role of Osimertinib in the TATTON Trial for Lung CancerПодробнее

Geoffrey Oxnard, MD, explains how genomic markers can guide treatment in PD-L1 positive NSCLCПодробнее

How lung cancer patients can help themselves: Dr. Geoffrey Oxnard| Dana-Farber Cancer InstituteПодробнее

What Urgent Innovations Can Advance Lung Cancer Precision Medicine?Подробнее

How Is Precision Medicine Used in the Treatment of Lung Cancer? | Dana-Farber Cancer InstituteПодробнее

Precision Medicine: Targeted Treatment for Lung CancerПодробнее

Precision Medicine in Lung Cancer: Where are We Today? A Medical Oncologist PerspectiveПодробнее

Geoffrey Oxnard, MD, on the effectiveness of lorlatinib as a frontline agent in ALK+ NSCLCПодробнее

Preview: The fast-paced field of lung cancer precision medicineПодробнее

Part 2 - Molecular and Precision Medicine (MAP) SeriesПодробнее

Dr. Geoffrey R. Oxnard Treating Patients Who Have Become Resistant to EGFR-InhibitorsПодробнее

Lung Cancer - interview with Geoff Oxnard, MD, at ASCO 2012Подробнее